Trial intelligence / Profile preview

Ceftazidime and Ciprofloxacin for prevention of infection in pediatric hematopoietic stem cell transplantation

IRCT20120415009475N8Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Aug 2020
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of ceftazidime and ciprofloxacin in Infection and febrile neutropenia (FN), sponsored by Shahid Beheshti University of Medical Sciences. Started Aug 2020; status: completed.

02

Drugs

ceftazidimeciprofloxacin
03

Conditions

Infectionfebrile neutropenia (FN)

Beyond the preview

Go deeper on IRCT20120415009475N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120415009475N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call